Brett T. Brinker

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino et al. · New England Journal of Medicine · 2024 · 150 citations · Full text

Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.

John D. Hainsworth, Kent C. Shih, Gregg C. Shepard et al. · PubMed · 2012 · 84 citations

Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma

Brett T. Brinker, Edmund K. Waller, Traci Leong et al. · Cancer · 2006 · 49 citations · Full text

Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine

Casey L. O’Connell, Maria R. Baer, Andreas Due Ørskov et al. · Clinical Cancer Research · 2022 · 24 citations · Full text

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino et al. · Hematological Oncology · 2023 · 20 citations · Full text

Immunodeficiencies, Immunology, Pathology +20